New research shows statin therapy significantly lowers hepatocellular carcinoma and hepatic decompensation risk while improving fibrosis outcomes in chronic liver disease patients with elevated FIB-4 scores.
"Chronic ethanol intake, through one of its main metabolic products, acetaldehyde, causes pathological changes in the gastrointestinal tract, liver, pancreas, and gallbladder. Even moderate amounts of alcohol may increase the risk of cancers, such as colorectal cancer."
Researchers found that universal hepatitis C screening guidelines increased testing rates in pregnant women, but overall uptake remained low, particularly among nonpregnant women.